Quick Answer
AVITA Medical, Inc. reported Stockholders Equity of -$16.65 million for the year ending 2025.
- AVITA Medical, Inc. showed a decrease of -470.1% in Stockholders Equity from 2024 to 2025.
- This data is from AVITA Medical, Inc.'s annual report (Form 10-K), filed with the SEC on February 12, 2026.
- XBRL data for this metric is available from 2017 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2019: $17.96 million | Q4 2019: $87.31 million | Q1 2020: $81.22 million | Q3 2020: $65.49 million | Q4 2020: $59.60 million | Q1 2021: $118.94 million | Q3 2021: $111.49 million | Q1 2022: $97.82 million | Q2 2022: $92.56 million | Q3 2022: $87.99 million | Q1 2023: $77.56 million | Q2 2023: $68.65 million | Q3 2023: $62.98 million | Q1 2024: $32.57 million | Q2 2024: $23.92 million | Q3 2024: $12.23 million | Q1 2025: -$4.57 million | Q2 2025: -$12.89 million | Q3 2025: -$6.67 million.
- Over the full 10 years of available data (2017 to 2025), AVITA Medical, Inc.'s Stockholders Equity has declined by 523.8%.
- Historical annual values: Fiscal year 2025: -$16.65 million | Fiscal year 2024: $4.50 million | Fiscal year 2023: $49.06 million | Fiscal year 2022: $84.74 million | Fiscal year 2021: $104.62 million | Fiscal year 2021: $115.66 million | Fiscal year 2020: $72.40 million | Fiscal year 2019: $20.83 million | Fiscal year 2018: $14.03 million | Fiscal year 2017: $3.93 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: